These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 37644910)

  • 41. Bayesian hierarchical modeling of patient subpopulations: efficient designs of Phase II oncology clinical trials.
    Berry SM; Broglio KR; Groshen S; Berry DA
    Clin Trials; 2013 Oct; 10(5):720-34. PubMed ID: 23983156
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Use of historical control data for assessing treatment effects in clinical trials.
    Viele K; Berry S; Neuenschwander B; Amzal B; Chen F; Enas N; Hobbs B; Ibrahim JG; Kinnersley N; Lindborg S; Micallef S; Roychoudhury S; Thompson L
    Pharm Stat; 2014; 13(1):41-54. PubMed ID: 23913901
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Elastic meta-analytic-predictive prior for dynamically borrowing information from historical data with application to biosimilar clinical trials.
    Zhang W; Pan Z; Yuan Y
    Contemp Clin Trials; 2021 Nov; 110():106559. PubMed ID: 34506959
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A Comparison Between a Meta-analytic Approach and Power Prior Approach to Using Historical Control Information in Clinical Trials With Binary Endpoints.
    Isogawa N; Takeda K; Maruo K; Daimon T
    Ther Innov Regul Sci; 2020 May; 54(3):559-570. PubMed ID: 33301135
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A dynamic power prior for borrowing historical data in noninferiority trials with binary endpoint.
    Liu GF
    Pharm Stat; 2018 Feb; 17(1):61-73. PubMed ID: 29125220
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bayesian borrowing for basket trials with longitudinal outcomes.
    Whitehead LE; Sailer O; Witham MD; Wason JMS
    Stat Med; 2023 Jul; 42(16):2819-2840. PubMed ID: 37120858
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A comparison of Bayesian information borrowing methods in basket trials and a novel proposal of modified exchangeability-nonexchangeability method.
    Daniells L; Mozgunov P; Bedding A; Jaki T
    Stat Med; 2023 Oct; 42(24):4392-4417. PubMed ID: 37614070
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Utilization of Adult Data in Designing Pediatric Pharmacokinetic Studies: How Much Are Historical Adult Data Worth?
    Hsu CH; Steven Xu X; Wang J; Zhang L; Liu C; Wang Y
    J Clin Pharmacol; 2019 Jul; 59(7):989-996. PubMed ID: 30748023
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A dynamic power prior approach to non-inferiority trials for normal means.
    Mariani F; De Santis F; Gubbiotti S
    Pharm Stat; 2024; 23(2):242-256. PubMed ID: 37964403
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Borrowing historical information to improve phase I clinical trials using meta-analytic-predictive priors.
    Chen X; Zhang J; Jiang Q; Yan F
    J Biopharm Stat; 2022 Jan; 32(1):34-52. PubMed ID: 35594366
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bayesian Design for Pediatric Clinical Trials with Binary Endpoints When Borrowing Historical Information of Treatment Effect.
    Jin M; Li Q; Kaur A
    Ther Innov Regul Sci; 2021 Mar; 55(2):360-369. PubMed ID: 32955713
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bayesian Method of Borrowing Study-Level Historical Longitudinal Control Data for Mixed-Effects Models with Repeated Measures.
    Li H; Jin M; Chung YC; Zhong S; Wang L
    Ther Innov Regul Sci; 2023 Jan; 57(1):142-151. PubMed ID: 36315398
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sample size calculation for clinical trials analyzed with the meta-analytic-predictive approach.
    Qi H; Rizopoulos D; van Rosmalen J
    Res Synth Methods; 2023 May; 14(3):396-413. PubMed ID: 36625478
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Incorporation of healthy volunteers data on receptor occupancy into a phase II proof-of-concept trial using a Bayesian dynamic borrowing design.
    Di Stefano F; Rodrigues C; Galtier S; Guilleminot S; Robert V; Gasparini M; Saint-Hilary G
    Biom J; 2023 Dec; 65(8):e2200305. PubMed ID: 37888795
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Utilizing shared internal control arms and historical information in small-sized platform clinical trials.
    Jiao F; Tu W; Jimenez S; Crentsil V; Chen YF
    J Biopharm Stat; 2019; 29(5):845-859. PubMed ID: 31462131
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vaccine clinical trials with dynamic borrowing of historical controls: Two retrospective studies.
    Callegaro A; Karkada N; Aris E; Zahaf T
    Pharm Stat; 2023; 22(3):475-491. PubMed ID: 36606496
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Incorporating historical controls in clinical trials with longitudinal outcomes using the modified power prior.
    Qi H; Rizopoulos D; Lesaffre E; van Rosmalen J
    Pharm Stat; 2022 Sep; 21(5):818-834. PubMed ID: 35128780
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Modified power prior with multiple historical trials for binary endpoints.
    Banbeta A; van Rosmalen J; Dejardin D; Lesaffre E
    Stat Med; 2019 Mar; 38(7):1147-1169. PubMed ID: 30360016
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Empirical profile Bayesian estimation for extrapolation of historical adult data to pediatric drug development.
    Wu Y; Hui J; Deng Q
    Pharm Stat; 2020 Nov; 19(6):787-802. PubMed ID: 32573051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.